Invicta Diagnostic SME GMP - Live Grey Market Premium

Alloted
Invicta Diagnostic SME

Invicta Diagnostics (PC Diagnostics) is a diagnostic chain operating primarily in the Mumbai Metropolitan Region (MMR). The company provides a one-stop solution by offering both radiology (X-ray, CT, MRI, PET CT) and pathology (routine and specialized tests) services through a hub-and-spoke model. The network includes 7 diagnostic centres and 1 centralised laboratory across MMR, ensuring high-end services are accessible. The company focuses on improving customer convenience through home sample collection and multiple report delivery options.

Issue Price
85
Current GMP
0
GMP %
0.00
Est. Listing Price
85
Advertisement

IPO Details

Price Range
₹80.0 - ₹85.0
Issue Size
₹28.12 Cr
Lot Size
1600 shares
IPO Type
NSE SME
Open Date
1 Dec 2025
Close Date
3 Dec 2025
Allotment Date
4 Dec 2025
Listing Date
8 Dec 2025

GMP Timeline

DateIPO PriceGMPEst. Price% Change
4 Dec 2025Live
85
0
85
0.00
3 Dec 2025
85
0
85
0.00
2 Dec 2025
85
3
88
+3.53
1 Dec 2025
85
0
85
0.00
30 Nov 2025
85
0
85
0.00
29 Nov 2025
85
0
85
0.00
28 Nov 2025
85
0
85
0.00
27 Nov 2025
85
0
85
0.00
26 Nov 2025
85
0
85
0.00
25 Nov 2025
85
0
85
0.00
Advertisement

Important Notes About Grey Market Premium

Grey Market Premium (GMP) is an unofficial value that indicates investor sentiment before the IPO listing. It is the premium amount at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.

GMP fluctuates based on market conditions and investor sentiment. A positive GMP suggests the market expects the stock to list above its issue price, while a negative GMP suggests it may list below the issue price.

The actual listing price may differ from the estimated price based on GMP due to market conditions on the listing day. GMP is not an official indicator and should not be the sole basis for investment decisions.

IPOwiz updates the GMP values regularly, but these values are sourced from unofficial channels and should be used as a reference only.

Back to GMP TrackerView Full IPO Details

Frequently Asked Questions

What is GMP (Grey Market Premium)?
GMP (Grey Market Premium) is the premium at which IPO shares are traded in the unofficial market before official listing. It indicates market sentiment and expected listing price. A positive GMP suggests strong demand, while negative GMP indicates weak market sentiment.
What is the current GMP for Invicta Diagnostic SME?
Currently, there is no GMP data available for Invicta Diagnostic SME. GMP values are updated regularly and may not be available for all IPOs.
What is the estimated listing price based on current GMP?
Estimated listing price cannot be calculated as GMP data is not currently available for Invicta Diagnostic SME.
How is GMP calculated?
GMP is determined by market demand and supply in the unofficial grey market. It's the difference between the expected listing price and the issue price. Higher GMP indicates strong demand and investor confidence, while lower or negative GMP suggests weak demand.
Is GMP reliable for IPO investment decisions?
GMP provides market sentiment but shouldn't be the sole factor for investment decisions. It's unofficial and can change daily. Consider company fundamentals, financials, market conditions, and your risk appetite before investing. GMP is a reference indicator, not a guarantee.
Can GMP change before listing?
Yes, GMP is highly volatile and can change daily based on market conditions, subscription levels, overall market sentiment, and news about the company. The GMP you see today may be different tomorrow, and it can change until 8 December 2025.
What happens if GMP is negative?
A negative GMP indicates the stock may list below the issue price, suggesting weak market demand. However, actual listing price may differ from GMP predictions, and negative GMP doesn't guarantee a loss.
How does GMP affect IPO subscription?
High GMP often correlates with high subscription rates as investors expect good listing gains. However, this isn't always true. Some IPOs with high GMP may have lower subscription if investors are cautious. GMP reflects market sentiment, which can influence subscription behavior.